Eva Froňková (Eva Fronkova)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Molecular biology reports

Journal of molecular medicine (Berlin, Germany)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia (2024)
Marketa Rackova, Rafael Mattera, Michael Svatoň, Filip Fencl, Veronika Kanderova, Karolina Spicakova, Sang Yoon Park, Ondrej Fabian, Miroslav Koblížek, Eva Froňková, Juan S Bonifacino, Karolina Skvarova Kramarzova
Revising pathogenesis of AP1S1-related MEDNIK syndrome: a missense variant in the AP1S1 gene as a causal genetic lesion. Journal of molecular medicine (Berlin, Germany) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Vincent H J van der Velden, Isabel Dombrink, Julia Alten, Giovanni Cazzaniga, Emmanuelle Clappier, Daniela Drandi, Cornelia Eckert, Eva Froňková, Jeremy Hancock, Michaela Kotrová, Rebekka Kraemer, Mirkka Montonen, Heike Pfeifer, Christiane Pott, Thorsten Raff, Heiko Trautmann, Hélène Cavé, Beat W Schäfer, Jacques J M van Dongen, Jan Trka, Monika Brüggemann, null null
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines. Leukemia 38 (6) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Martin Schwarz, Matej Gazdarica, Eva Froňková, Michael Svatoň, Jiri Bronsky, Markéta Havlovicová, Anna Křepelová, Milan Macek
Functional studies associate novel DUOX2 gene variants detected in heterozygosity to Crohn's disease. Molecular biology reports 51 (1) (2024)
Vincent H J van der Velden, Isabel Dombrink, Julia Alten, Giovanni Cazzaniga, Emmanuelle Clappier, Daniela Drandi, Cornelia Eckert, Eva Froňková, Jeremy Hancock, Michaela Kotrová, Rebekka Kraemer, Mirkka Montonen, Heike Pfeifer, Christiane Pott, Thorsten Raff, Heiko Trautmann, Hélène Cavé, Beat W Schäfer, Jacques J M van Dongen, Jan Trka, Monika Brüggemann, null null
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines. Leukemia 38 (6) (2024)
Martin Schwarz, Matej Gazdarica, Eva Froňková, Michael Svatoň, Jiri Bronsky, Markéta Havlovicová, Anna Křepelová, Milan Macek
Functional studies associate novel DUOX2 gene variants detected in heterozygosity to Crohn's disease. Molecular biology reports 51 (1) (2024)
Vincent H J van der Velden, Isabel Dombrink, Julia Alten, Giovanni Cazzaniga, Emmanuelle Clappier, Daniela Drandi, Cornelia Eckert, Eva Froňková, Jeremy Hancock, Michaela Kotrová, Rebekka Kraemer, Mirkka Montonen, Heike Pfeifer, Christiane Pott, Thorsten Raff, Heiko Trautmann, Hélène Cavé, Beat W Schäfer, Jacques J M van Dongen, Jan Trka, Monika Brüggemann, null null
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines. Leukemia 38 (6) (2024)
Vincent H J van der Velden, Isabel Dombrink, Julia Alten, Giovanni Cazzaniga, Emmanuelle Clappier, Daniela Drandi, Cornelia Eckert, Eva Froňková, Jeremy Hancock, Michaela Kotrová, Rebekka Kraemer, Mirkka Montonen, Heike Pfeifer, Christiane Pott, Thorsten Raff, Heiko Trautmann, Hélène Cavé, Beat W Schäfer, Jacques J M van Dongen, Jan Trka, Monika Brüggemann, null null
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines. Leukemia (2024)
Vincent H J van der Velden, Isabel Dombrink, Julia Alten, Giovanni Cazzaniga, Emmanuelle Clappier, Daniela Drandi, Cornelia Eckert, Eva Froňková, Jeremy Hancock, Michaela Kotrová, Rebekka Kraemer, Mirkka Montonen, Heike Pfeifer, Christiane Pott, Thorsten Raff, Heiko Trautmann, Hélène Cavé, Beat W Schäfer, Jacques J M van Dongen, Jan Trka, Monika Brüggemann, null null
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines. Leukemia 38 (6) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Michael Svatoň, Aneta Skotnicova, Leona Reznickova, Andrea Rennerova, Tatana Valova, Michaela Kotrová, Vincent H J van der Velden, Monika Brüggemann, Nikos Darzentas, Anton W Langerak, Jan Zuna, Jan Stary, Jan Trka, Eva Froňková
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol. Blood (2022)
Dana Prukova, Ladislav Andera, Zuzana Nahacka, Jana Karolova, Michael Svaton, Magdalena Klanova, Ondrej Havranek, Jan Soukup, Karla Svobodova, Zuzana Zemanova, Diana Tuskova, Eva Pokorna, Karel Helman, Kristina Forsterova, Mariana Pacheco-Blanco, Petra Vockova, Adela Berkova, Eva Froňková, Marek Trneny, Pavel Klener
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (14) (2019)
Claire Schwab, Karin Nebral, Lucy Chilton, Cristina Leschi, Esmé Waanders, Judith M Boer, Markéta Žaliová, Rosemary Sutton, Ingegerd Ivanov Öfverholm, Kentaro Ohki, Yuka Yamashita, Stefanie Groeneveld-Krentz, Eva Froňková, Marleen Bakkus, Joelle Tchinda, Thayana da Conceição Barbosa, Grazia Fazio, Wojciech Mlynarski, Agata Pastorczak, Giovanni Cazzaniga, Maria S Pombo-de-Oliveira, Jan Trka, Renate Kirschner-Schwabe, Toshihiko Imamura, Gisela Barbany, Martin Stanulla, Andishe Attarbaschi, Renate Panzer-Grümayer, Roland P Kuiper, Monique L den Boer, Hélène Cave, Anthony V Moorman, Christine J Harrison, Sabine Strehl
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia? Blood advances 1 (19) (2017)